Study: BP, CVD risk should be considered in hypertension diagnosis, treatment | Extreme prematurity tied to increased high BP risk in adulthood | Long naps tied to higher diabetes risk, study says
September 19, 2016
AANP SmartBrief
News for nurse practitioners
Health Care News
Study: BP, CVD risk should be considered in hypertension diagnosis, treatment
A study in JAMA Cardiology suggests clinicians need to consider a patient's blood pressure and cardiovascular disease risk factors, rather than use clinical trial criteria, to diagnose hypertension and decide on a treatment approach. The findings, based on data for 14,142 adults ages 20 to 79, showed that having a systolic blood pressure of 120 mm Hg to 139 mm Hg or a high risk for cardiovascular diseases would not qualify many patients for the Systolic Blood Pressure Intervention Trial or the Heart Outcomes Prevention Evaluation-3 trial.
Medscape (free registration) (9/16) 
LinkedIn Twitter Facebook Google+ Email
Extreme prematurity tied to increased high BP risk in adulthood
Researchers found that young adults born very preterm had smaller kidneys and average systolic blood pressure that was 5 points higher than those born full term. Another study showed slower endothelial cell colony formation involved in creating new capillaries among those born at 29 weeks of gestation or earlier compared with those born full term. Both studies were presented at the American Heart Association meeting.
HealthDay News (9/15) 
LinkedIn Twitter Facebook Google+ Email
Long naps tied to higher diabetes risk, study says
A study found naps lasting one hour or more were linked to a 45% increased risk of diabetes, while no risk was seen with shorter naps, researchers told the European Association for the Study of Diabetes. Dr. Joel Zonszein of the Montefiore Medical Center commented longer naps may be a lifestyle marker, possibly linked to stress, long working hours or poor diet, which could contribute to the risk of diabetes.
HealthDay News (9/15) 
LinkedIn Twitter Facebook Google+ Email
Research links diabetes to pancreatic cancer
A Czech study presented at the European Association for the Study of Diabetes meeting showed an association between diabetes and pancreatic cancer, particularly new-onset diabetes. Researchers said certain patients with new-onset diabetes, including those who are lean, have lost weight or whose disease is worsening rapidly, should be evaluated for pancreatic cancer.
Healio (free registration)/Endocrine Today (9/15) 
LinkedIn Twitter Facebook Google+ Email
1st USP Certified Gummy Brand
Nature Made® Adult Gummies are the first vitamin gummy brand on the market to receive the United States Pharmacopeia (USP) Verified Mark. This quality verification indicates that the products meet stringent criteria for purity and potency. Click here to learn more
Pharmaceutical News
Metformin tied to lower citrulline levels in diabetes, study finds
Type 2 diabetes patients treated with metformin had lower values of citrulline, compared with those who didn't take any anti-diabetes medication, according to a study in Diabetes. German researchers used a cohort of 189 diabetes patients and found those who started using metformin had a significant reduction in citrulline values at seven years, with comparable results seen in the epididymal adipose tissue, plasma and skeletal muscle of metformin-treated mice.
Physician's Briefing/HealthDay News/HealthDay News (9/15) 
LinkedIn Twitter Facebook Google+ Email
Study shows experimental shingles vaccine effective for older patients
The experimental shingles vaccine Shingrix was 90% effective in patients over age 70 after four years, researchers reported in The New England Journal of Medicine. Data from a separate Kaiser Permanente study showed the Zostavax vaccine had reduced efficacy as people aged, decreasing to around 18% for adults older than 79.
Reuters (9/14) 
LinkedIn Twitter Facebook Google+ Email
Clarifying OTC Analgesic Dosing for Patients
HCPs have an opportunity to educate patients on specific OTC analgesic dosing instructions at each visit to help ensure safe use. Clarifying the OTC maximum daily doses of common analgesics (4000 mg for acetaminophen, 1200 mg for ibuprofen, 660 mg for naproxen sodium) can reduce patient confusion.
Hot Topics
In-home AHRAs: A Best Practice Model for Changing Times
Annual health risk assessments (AHRA's) are a critical component of accurate risk-adjustment coding under Medicare Advantage. Learn how a partner driven approach to in-home assessments can result in improved quality of life and care for members, along with improved outcomes for health plans, and result in more accurate, appropriate and complete identification of high risk diagnoses for coding accuracy. Click here to download the white paper.
Emerging Trends, Products and Technologies
CDC reports brain cancer as top cause of pediatric cancer deaths
A report from the CDC's Center for National Health Statistics found that brain cancer was the leading cause of pediatric cancer deaths after deaths rose from 516 in 1999 to 534 in 2014, while leukemia deaths declined from 645 to 445. The findings also showed that overall cancer mortality among youths declined by 20% over the same period.
Reuters (9/16),  The Washington Post (tiered subscription model) (9/16) 
LinkedIn Twitter Facebook Google+ Email
Study: Incentive program has little effect on preventive care
Data showed similar racial disparities in preventive care before and after the CMS Quality Bonus Payment Demonstration in Medicare Advantage, which was introduced in 2012, researchers reported in the journal Preventing Chronic Disease. Researchers studied whether program incentives affected preventive care in the areas of improving bladder control, reducing risks of falls, and physical activity monitoring.
Healio (free registration) (9/14) 
LinkedIn Twitter Facebook Google+ Email
Study shows efficacy of CGM in reducing hypoglycemia in diabetes
Dutch researchers looked at 52 type 1 diabetes patients with impaired hypoglycemia awareness and found those who used a real-time continuous glucose monitoring device had 6.8% of time spent in hypoglycemia, compared with 11.4% in the standard self-monitoring group. The findings, presented at the European Association for the Study of Diabetes meeting and published in The Lancet Diabetes and Endocrinology, also showed those in the CGM group had 14 severe hypoglycemic events that required third-party assistance, compared with 34 in the self-monitoring group.
MedPage Today (free registration) (9/15) 
LinkedIn Twitter Facebook Google+ Email
Health Policy and Legislative News
Zika transmission zone grows in Miami Beach, Fla.
Florida Gov. Rick Scott announced that the area where the Zika virus is being transmitted in Miami Beach has grown to about 4.5 square miles. The state will spend an additional $10 million on mosquito control, laboratory testing and Zika prevention kits.
WUSF-FM (Tampa, Fla.)/The Associated Press (9/18),  WUSF-FM (Tampa, Fla.)/The Associated Press (9/18),  The Miami Herald (tiered subscription model) (9/17) 
LinkedIn Twitter Facebook Google+ Email
T2DM Patient Toolkit
In an ongoing effort to provide AANP members with effective tools to improve clinical practice, AANP, in collaboration with educational partner Med-IQ, has developed a series of educational resources that can be used during discussions with patients who have type 2 diabetes mellitus (T2DM). This packet includes:
  • Twenty 4"x9", identical cards and one card holder to be placed in your examination room. These cards can prompt patients to ask questions about their current T2DM management.
  • Two 8.5”x11”, double-sided, laminated handouts to be placed in your examination room. These handouts can be used to illustrate complex concepts to patients about appropriate T2DM management and GLP-1 receptor agonist use.
This patient engagement toolkit may be ordered at no charge through PatientEngagementToolkit. There is a limited quantity available.
LinkedIn Twitter Facebook Google+ Email
State Award for Excellence Deadline Approaching
With less than a month until the nominations period for the AANP 2017 State Award for Excellence closes on Oct. 10, you still have time to nominate a colleague for these prestigious awards. The NP State Award for Excellence is given annually to an individual nurse practitioner in each state who has demonstrated excellence in NP clinical practice. The Advocate State Award for Excellence is given annually to an individual in each state who has made a significant contribution toward increasing awareness and recognition of the NP role. NPs are also eligible for the advocate award for nonclinical initiatives related to leadership, precepting, policy, politics, research, education or community affairs. The deadline for nominations to be received by AANP is Oct. 10. You do not have to be an AANP member to nominate someone or to be nominated for either award. For more information and to begin the nomination process, visit
LinkedIn Twitter Facebook Google+ Email
Learn more about AANP:
Home Page | Join AANP | Legislation/Practice
AANP JobCenter | AANP Store
I never dreamed about success. I worked for it.
Estee Lauder,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information